Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid in Capital. Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid in Capital.	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Accumulated Other Comprehensive Income (Loss) Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Income (Loss)	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Total
Beginning balance at Dec. 31, 2022	$ 19,992	$ 19,992	$ 155,095	$ 155,095	$ (4,452)	$ 275,974	$ 280,426	$ (98,641)	$ (98,641)	$ (4,452)	$ 352,420	$ 356,872
Net Income							8,186					8,186
Other comprehensive income (loss)									2,334			2,334
Common stock repurchased		(17)		(344)								(361)
Common stock dividends							(3,620)					(3,620)
Share-based compensation expense				159								159
Vesting of restricted stock		92		(92)
Ending balance at Mar. 31, 2023		20,067		154,818			280,540		(96,307)			359,118
Beginning balance at Dec. 31, 2023		19,734		150,343			272,705		(73,655)			369,127
Net Income							6,432					6,432
Other comprehensive income (loss)									(601)			(601)
Common stock repurchased		(7)		(146)								(153)
Common stock dividends							(3,763)					(3,763)
Share-based compensation expense				593								593
Vesting of restricted stock		50		(50)
Ending balance at Mar. 31, 2024		$ 19,777		$ 150,740			$ 275,374		$ (74,256)			$ 371,635